Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1

J Biol Chem. 1994 Jul 22;269(29):19021-7.

Abstract

Although tumor necrosis factor (TNF) and interleukin-1 (IL) induce the expression of the IL-8, TNF-stimulated gene 6, and plasminogen activation inhibitor-2 genes and the activation of NF-kappa B with nearly identical kinetics, the two cytokines differ significantly in the induction of the IL-6 gene in all primary fibroblasts tested. IL-1 induces IL-6 gene expression after 30 min of IL-1 treatment, reaching a maximum level by 7 h, and is sustained for up to 14 h. TNF also induces the IL-6 gene expression at 30 min but the induction was low. A similar differences in the amount of IL-6 secreted was observed in the IL-1/TNF-treated cells. Measurement of IL-6 gene transcription by nuclear run-on transcription assays indicated a 4-fold higher rate of IL-6 gene transcription in IL-1-treated than in TNF-treated cells. The IL-1-induced IL-6 mRNA has a significantly longer half-life (> 6 h) compared to 30 min for TNF-treated cells. These results suggest that the induction of the IL-6 gene expression in primary human fibroblasts by TNF and IL-1 is differentially regulated at the transcriptional as well as at the post-transcriptional level.

MeSH terms

  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects*
  • Genes
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / administration & dosage*
  • Interleukin-6 / genetics*
  • Interleukin-6 / metabolism
  • Interleukin-8 / genetics
  • NF-kappa B / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Time Factors
  • Transcription, Genetic / drug effects
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interleukin-1
  • Interleukin-6
  • Interleukin-8
  • NF-kappa B
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Dactinomycin